| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $6.96B | $5.63B | $4.88B | $6.02B | $6.42B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $7.03B | $5.78B | $5.20B | $6.61B | $6.91B |
| R&D | $245.80M | $188.80M | $184.50M | $360.30M | $365.30M |
| SG&A | $144.30M | $165.20M | $125.70M | $208.10M | $288.50M |
| Operating Income | -$63.40M | -$154.80M | -$314.90M | -$589.40M | -$493.00M |
| Interest Expense | – | – | $10.80M | $3.60M | $2.40M |
| Tax Expense | -$1.10M | -$500.00K | -$400.00K | -$900.00K | -$2.50M |
| Net Income | -$58.50M | -$154.40M | -$321.30M | -$601.50M | -$494.10M |
| EPS (basic) | -0.1000 | -0.3100 | -0.6900 | -1.4000 | -1.5100 |
| EPS (diluted) | -0.1000 | -0.3100 | -0.6900 | -1.4000 | -1.5100 |
| Shares (diluted) | $562.15M | $501.51M | $466.52M | $428.17M | $326.34M |